When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FATE - Fate Therapeutics on go to advance CAR T candidate FT819 into the clinic
Fate Therapeutics Inc.
The FDA has signed off on Fate Therapeutics' (NASDAQ:FATE) IND to start clinical development of FT819, an off-the-shelf allogeneic chimeric antigen receptor (CAR) T-cell therapy targeting CD19+ malignancies.
More news on: Fate Therapeutics, Inc., Healthcare stocks news, Stocks on the move,